Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001672520-17-000002
Filing Date
2017-11-22
Accepted
2017-11-22 14:36:51
Documents
1
Effectiveness Date
2017-11-22
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 7479
  Complete submission text file 0001672520-17-000002.txt   8517
Mailing Address 222 THIRD STREET, SUITE 2240 CAMBRIDGE MA 02142
Business Address 222 THIRD STREET, SUITE 2240 CAMBRIDGE MA 02142 617-225-7700
Censa Pharmaceuticals Inc. (Filer) CIK: 0001672520 (see all company filings)

EIN.: 474109603 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-299411 | Film No.: 171219639